Health Care Continues to Drive False Claims Act Recoveries: Thought Leaders in Health Law Video SeriesJanuary 2020
$3 billion recovered under the False Claims Act (“FCA”). That’s what the US Department of Justice (“DOJ”) reported collecting in FY2019. The health care and life sciences industries accounted for $2.6 billion of the total recoveries. That’s 87% of all FCA judgments and settlements. $678 million of the health care recoveries came from DOJ initiated enforcement actions. $1.9 billion of the health care recoveries were generated by cases brought by whistleblowers who filed qui tam actions. Qui tam actions remain a principal driver of FCA enforcement in the health care space.
Enforcement targeted pharmaceutical and medical device companies, managed care entities, hospitals, pharmacies, hospice organizations, laboratories, and physicians. The recoveries also reflect DOJ’s intent to hold individuals, not only corporations, accountable in FCA cases.
Stay up to date, and learn how to protect yourself and your company, at healthlawadvisor.com.
The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.
Trouble viewing the video? Please contact Kelli Sakalousky at [email protected] and mention whether you were at home or working within a corporate network. We'd also love your suggestions for future topics. Subscribe to our Health Care and Life Sciences email list to be notified of future video releases.
THOUGHT LEADERS IN HEALTH LAW® is a registered trademark of Epstein Becker & Green, P.C.